SCHEMBL6025148

SCHEMBL6025148

Cc1nc(O)c2cccc(Br)c2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.44
GAA P10253 1/20 0.44
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.39
ENPP3 O14638 1/20 0.38
ENPP1 P22413 1/20 0.38
HRH4 Q9H3N8 1/20 0.37
AR P10275 1/20 0.36
PRNP P04156 1/20 0.35
BACE1 P56817 1/20 0.35
NQO2 P16083 1/20 0.34
ADORA1 P30542 1/20 0.34
PDE7A Q13946 1/20 0.34
CYP1A2 P05177 2/20 0.33
CYP2A6 P11509 2/20 0.33
HTT P42858 2/20 0.33
KDM4E B2RXH2 2/20 0.33
SLC6A2 P23975 1/20 0.33
PARP1 P09874 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL558684 0.81 MAPT (0.40) MAPTGAAALDH1A1SMN1; SMN2ENPP3
SCHEMBL29209692 0.78 HRH4 (0.47) MAPTGAAALDH1A1SMN1; SMN2ENPP3
SCHEMBL6026073 0.78 ALDH1A1 (0.49) MAPTGAAALDH1A1SMN1; SMN2ENPP3
SCHEMBL5753222 0.78 ENPP3 (0.45) MAPTGAAALDH1A1SMN1; SMN2ENPP3
SCHEMBL30881846 0.78 HRH4 (0.47) MAPTGAAALDH1A1SMN1; SMN2ENPP3
SCHEMBL5249809 0.76 MAPT (0.57) MAPTGAAALDH1A1SMN1; SMN2ENPP3
SCHEMBL2712037 0.76 MAPT (0.43) MAPTGAAALDH1A1SMN1; SMN2ENPP3
SCHEMBL30612099 0.73 MAPT (0.47) MAPTGAAALDH1A1SMN1; SMN2ENPP3
SCHEMBL28571141 0.70 HPGD (0.41) MAPTGAAALDH1A1SMN1; SMN2BACE1
SCHEMBL15228487 0.70 ALDH1A1 (0.36) MAPTGAAALDH1A1SMN1; SMN2ENPP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0966442-B1 QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONIST ACTIVITY DUPHAR INT RES (NL) 2006-12-20 EP disclosed
US-6350750-B1 TREATMENT OF STRESS-RELATED DISORDERS; ARYLATION WITH BORONIC ACID DERIVATIVE, AMINATION DUPHAR INTERNATIONAL RESEARCH B.V. (NL) 2002-02-26 US disclosed
EP-0966442-A1 QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONIST ACTIVITY DUPHAR INTERNATIONAL RESEARCH B.V (NL) 1999-12-29 EP disclosed
WO-1999012908-A1 QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONIST ACTIVITY DUPHAR INTERNATIONAL RESEARCH B.V. (NL) 1999-03-18 WO disclosed